Gore Range Capital, a Southlake-based healthcare venture capital firm, has added the New York dermatologist Richard D. Granstein to the industry advisory Board of the firm's Gore Range Capital Fund II.
Granstein joins nine other skin health leaders on the board, which works with Gore Range Capital to find, vet, and support early-stage companies that have innovative treatments and technologies for skin health.
“We are pleased to welcome another world-class skin health leader to our IAB," Ethan Rigel, Gore Range's founding and managing partner, said in a release. "Dr. Granstein adds vast skin immunology expertise and additional industry leadership to our team.”
“Joining Gore Range Capital’s IAB is a great opportunity to work with like-minded professionals who are dedicated to identifying and supporting new innovations in skin health that will improve patient care and outcomes,” Granstein said in the release.
Granstein, a board-certified dermatologist and researcher, is chair of dermatology at Weill Cornell Medicine and dermatologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center.
During his four-decade career, Granstein's research interests have centered on the regulation of immunity within the skin and relationship of the skin immune system to the development of skin cancers.
"He was the first to demonstrate that immune cells within the epidermis (the upper layer of the skin) have an anatomic relationship with nerves and can be regulated by certain proteins produced by those nerves," Gore Range said. "His clinical interests include autoimmune disorders of the skin, skin cancer and psoriasis."
Granstein obtained his undergraduate education at Massachusetts Institute of Technology and his M.D. at the UCLA School of Medicine. After completing his internship in 1979, he trained in dermatology at the Massachusetts General Hospital, studied immunology and tumor biology at the National Cancer Institute-Frederick Cancer Research Facility and, subsequently, at Harvard Medical School.
Granstein served on the faculty of the Department of Dermatology at Harvard Medical School and the Massachusetts General Hospital before joining Weill Cornell Medicine and NewYork-Presbyterian Hospital.
Granstein is on the board of the American Skin Association, and he chairs the Medical Advisory Board of the National Rosacea Foundation. He is former vice president of the Society for Investigative Dermatology and is president-elect of the Association of Professors of Dermatology. He has served as principal investigator for numerous research grants and trials.
Gore Range is a venture capital firm investing in early-stage healthcare businesses with a focus on skin health. The firm blends the hands-on approach of operationally focused private equity with the early-stage guidance needed in venture capital. Gore Range offers capital, and operational, clinical, and scientific expertise that leverages the team’s deep industry relationships and industry advisory board.
Do you have a story you'd like to share with Fort Worth Inc. readers? Please send an email to our editor, Scott Nishimura.